Tobam Gilead Sciences, Inc. Transaction History

Tobam

$328 Million
Q4 2024

A detailed history of Tobam transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tobam holds 9,275 shares of GILD stock, worth $1.07 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

9,275

Previous 12,962 28.44%

Holding current value

$1.07 Million

Previous $1.09 Million 21.16%

% of portfolio

0.26%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$83.95 - $97.9 $309,523 - $360,957	-3,687 Reduced 28.44%	9,275 $857,000
Q3 2024 Oct 09, 2024	BUY	$66.59 - $83.99 $48,610 - $61,312	730 Added 5.97%	12,962 $1.09 Million
Q2 2024 Jul 29, 2024	SELL	$63.15 - $72.88 $892,435 - $1.03 Million	-14,132 Reduced 53.6%	12,232 $839,000
Q4 2023 Jan 26, 2024	SELL	$73.27 - $83.09 $302,605 - $343,161	-4,130 Reduced 13.54%	26,364 $2.14 Million
Q3 2023 Oct 31, 2023	SELL	$73.94 - $80.67 $153,647 - $167,632	-2,078 Reduced 6.38%	30,494 $2.29 Million
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $2.87 Million - $3.27 Million	-37,695 Reduced 53.65%	32,572 $2.51 Million
Q1 2023 May 03, 2023	SELL	$77.31 - $88.08 $6.46 Million - $7.36 Million	-83,576 Reduced 54.33%	70,267 $5.83 Million
Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $3.73 Million - $5.35 Million	-59,844 Reduced 28.01%	153,843 $13.2 Million
Q3 2022 Nov 02, 2022	SELL	$59.54 - $68.01 $5.08 Million - $5.8 Million	-85,283 Reduced 28.53%	213,687 $13.2 Million
Q2 2022 Aug 02, 2022	SELL	$57.72 - $65.01 $29.1 Million - $32.8 Million	-504,021 Reduced 62.77%	298,970 $18.5 Million
Q1 2022 Apr 25, 2022	SELL	$57.92 - $72.58 $5.83 Million - $7.3 Million	-100,590 Reduced 11.13%	802,991 $47.7 Million
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $4.13 Million - $4.69 Million	-63,697 Reduced 6.59%	903,581 $65.6 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $5.61 Million - $6.05 Million	-82,867 Reduced 7.89%	967,278 $67.6 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $1.76 Million - $1.92 Million	-27,705 Reduced 2.57%	1,050,145 $72.3 Million
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $493,380 - $562,946	-8,223 Reduced 0.76%	1,077,850 $69.7 Million
Q4 2020 Feb 03, 2021	BUY	$56.65 - $64.55 $8.78 Million - $10 Million	154,918 Added 16.64%	1,086,073 $63.3 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $32.3 Million - $40.6 Million	519,455 Added 126.17%	931,155 $58.8 Million
Q2 2020 Aug 17, 2020	BUY	$72.34 - $84.0 $29.8 Million - $34.6 Million	411,700 New	411,700 $31.7 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $590,586 - $719,990	-8,108 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $22,839 - $26,809	-321 Reduced 3.81%	8,108 $581,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $607,815 - $720,426	8,429	8,429 $683,000

Others Institutions Holding GILD

# of Institutions

2,098

Shares Held

1.02B

Call Options Held

8.73M

Put Options Held

9.63M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $145B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account